Patient perceptions of insulin therapy in diabetes self-management with insulin injection devices.

Publication Year: 2023

DOI:
10.1007/s00592-023-02054-7

PMCID:
PMC10063495

PMID:
36828942

Journal Information

Full Title: Acta Diabetol

Abbreviation: Acta Diabetol

Country: Unknown

Publisher: Unknown

Language: N/A

Publication Details

Subject Category: Endocrinology

Available in Europe PMC: Yes

Available in PMC: Yes

PDF Available: No

Transparency Score
3/6
50.0% Transparent
Transparency Indicators
Click on green indicators to view evidence text
Core Indicators
Data Sharing
Code Sharing
Evidence found in paper:

"Declarations Conflict of interestA.C. has received consulting or speaker fees from Bristol Meyer Squibb, AstraZeneca, Boehringer Ingelheim, Eli Lilly, Merck Sharp & Dohme, Novartis, Novo-Nordisk, Sanofi-Aventis, Sigma-Tau, Takeda. G.F. declares that she has no conflict of interest. Human and Animal RightsThis survey was designed and conducted consistent with the ethical principles outlined in the 2016 Declaration of Helsinki. Informed consentInformed consent was obtained from all individual respondents to this online survey. Conflict of interest A.C. has received consulting or speaker fees from Bristol Meyer Squibb, AstraZeneca, Boehringer Ingelheim, Eli Lilly, Merck Sharp & Dohme, Novartis, Novo-Nordisk, Sanofi-Aventis, Sigma-Tau, Takeda. G.F. declares that she has no conflict of interest."

Evidence found in paper:

"Funding Open access funding provided by Università degli Studi G. D'Annunzio Chieti Pescara within the CRUI-CARE Agreement."

Protocol Registration
Open Access
Paper is freely available to read
Additional Indicators
Replication
Novelty Statement
Assessment Info

Tool: rtransparent

OST Version: N/A

Last Updated: Aug 05, 2025